ASX Penny Stocks To Watch In August 2026

As the S&P/ASX 200 index is poised to edge lower amid rising oil prices and geopolitical tensions, investors are closely watching how these factors might impact the broader Australian market. In such fluctuating conditions, penny stocks—often representing smaller or emerging companies—continue to capture attention for their potential to uncover hidden value. While the term may seem outdated, these stocks can offer significant growth opportunities when backed by solid financial health, making them a compelling area of interest for those seeking long-term potential in today's market landscape.

Below we spotlight a couple of our favorites from our exclusive screener.

Australian Ethical Investment (ASX:AEF)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Australian Ethical Investment Ltd is a publicly owned investment manager with a market cap of A$523.62 million.

Operations: The company generates revenue from its Funds Management segment, which amounted to A$126.41 million.

Market Cap: A$523.62M

Australian Ethical Investment Ltd, with a market cap of A$523.62 million, has demonstrated strong financial health and growth potential. The company reported revenues of A$126.41 million from its Funds Management segment and no debt for the past five years, alleviating concerns over interest payments. Its short-term assets significantly exceed both short-term and long-term liabilities. Earnings grew by 62.2% last year, surpassing the industry average, while maintaining an outstanding return on equity at 52%. Despite an unstable dividend track record, its experienced management team and high-quality earnings underscore a robust operational framework for investors considering penny stocks in Australia.

• Jump into the full analysis health report here for a deeper understanding of Australian Ethical Investment.
• Examine Australian Ethical Investment's earnings growth report to understand how analysts expect it to perform.

American Rare Earths (ASX:ARR)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: American Rare Earths Limited, with a market cap of A$206.21 million, explores and develops mineral resources in the United States through its subsidiaries.

Operations: Currently, there are no reported revenue segments for this mineral exploration and development company operating in the United States.

Market Cap: A$206.21M

American Rare Earths Limited, with a market cap of A$206.21 million, is pre-revenue and focuses on mineral exploration in the U.S., notably advancing its Halleck Creek Rare Earths Project in Wyoming. Recent executive appointments aim to progress feasibility studies and construction efforts. The company remains debt-free, providing financial flexibility as it navigates high share price volatility typical of penny stocks. Despite an inexperienced management team, the board's seasoned expertise supports strategic development initiatives. Current drilling activities are geared towards resource estimation and project expansion potential, while a planned NASDAQ dual listing reflects its ambition for broader market engagement.

• Dive into the specifics of American Rare Earths here with our thorough balance sheet health report.
• Learn about American Rare Earths' future growth trajectory here.

XRF Scientific (ASX:XRF)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: XRF Scientific Limited manufactures and markets precious metal products, specialized chemicals, and instruments for the scientific, analytical, construction material, and mining industries across Australia, Canada, and Europe with a market cap of A$268.92 million.

Operations: The company's revenue is derived from three main segments: Consumables generating A$18.07 million, Precious Metals contributing A$23.79 million, and Capital Equipment accounting for A$24.60 million.

Market Cap: A$268.92M

XRF Scientific Limited, with a market cap of A$268.92 million, demonstrates financial stability and growth potential. The company has diversified revenue streams from Consumables (A$18.07M), Precious Metals (A$23.79M), and Capital Equipment (A$24.60M). XRF's short-term assets significantly exceed both its short- and long-term liabilities, highlighting strong liquidity management. The debt to equity ratio has notably decreased over five years, reflecting prudent financial strategies, while earnings have consistently grown by 12.9% annually, outpacing the industry average decline of -3.8%. Additionally, the company's interest payments are well covered by EBIT at 76.8 times coverage.

• Click to explore a detailed breakdown of our findings in XRF Scientific's financial health report.
• Understand XRF Scientific's earnings outlook by examining our growth report.

Next Steps

• Click this link to deep-dive into the 408 companies within our ASX Penny Stocks screener.
• Contemplating Other Strategies? The end of cancer? These 33 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com